Roberto Garcia Swinburn

Artiklar

Journal article: BRAIN STRUCTURE AND FUNCTION. 2023;228(3-4):907-920
Extracellular matrix protein anosmin-1 overexpression alters dopaminergic phenotype in the CNS and the PNS with no pathogenic consequences in a MPTP model of Parkinson's disease
Villadiego J; Garcia-Swinburn R; Garcia-Gonzalez D; Lebron-Galan R; Murcia-Belmonte V; Garcia-Roldan E; Suarez-Luna N; Nombela C; Marchena M; de Castro F; Toledo-Aral JJ
Journal article: NATURE NEUROSCIENCE. 2023;26(2):226-238
Full protection from SARS-CoV-2 brain infection and damage in susceptible transgenic mice conferred by MVA-CoV2-S vaccine candidate
Villadiego J; Garcia-Arriaza J; Ramirez-Lorca R; Garcia-Swinburn R; Cabello-Rivera D; Rosales-Nieves AE; Alvarez-Vergara MI; Cala-Fernandez F; Garcia-Roldan E; Lopez-Ogayar JL; Zamora C; Astorgano D; Albericio G; Perez P; Munoz-Cabello AM; Pascual A; Esteban M; Lopez-Barneo J; Toledo-Aral JJ
Journal article: XENOTRANSPLANTATION. 2018;25(6):e12410
Long-term immunosuppression for CNS mouse xenotransplantation: Effects on nigrostriatal neurodegeneration and neuroprotective carotid body cell therapy
Villadiego J; Romo-Madero S; Garcia-Swinburn R; Suarez-Luna N; Bermejo-Navas A; Echevarria M; Toledo-Aral JJ

Preprint: BIORXIV. 2022
Extracellular matrix protein anosmin-1 overexpression regulates dopaminergic phenotype in the CNS and the PNS with no pathogenic consequences in MPTP model of Parkinson’s disease
Villadiego J; García-Swinburn R; García-González D; Lebrón-Galán R; Murcia-Belmonte V; García-Roldán E; Suárez-Luna N; Nombela C; Marchena M; de Castro F; Toledo-Aral JJ
Preprint: RESEARCH SQUARE. 2022
MVA-CoV2-S vaccine candidate confers full protection from SARS-CoV-2 brain infection and damage in susceptible transgenic mice
Villadiego J; García-Arriaza J; Ramírez-Lorca R; Cabello-Rivera D; Álvarez-Vergara M; Cala-Fernández F; García-Swinburn R; García-Roldán E; López-Ogáyar J; Zamora C; Astorgano D; Pérez P; Rosales-Nieves A; Muñoz-Cabello A; Pascual A; Esteban M; Lopez-Barneo J; Toledo-Aral J

Anknuten till Forskning, Medicinsk biokemi och biofysik, Karolinska Institutet, 2023-2025
Postdoktor, Medicinsk biokemi och biofysik, Karolinska Institutet, 2023-2025